Literature DB >> 1544477

Biphasic transition curve on denaturation of chicken cystatin by guanidinium chloride. Evidence for an independently unfolding structural region.

I Björk1, E Pol.   

Abstract

Far-ultraviolet circular dichroism and tryptophan fluorescence measurements showed that the reversible unfolding of the cysteine proteinase inhibitor, chicken cystatin, by guanidinium chloride is a two-step process with transition midpoints at approximately 3.4 and approximately 5.4 M denaturant. The partially unfolded intermediate had both far- and near-ultraviolet circular dichroism and fluorescence emission spectra comparable to those of the native protein. The largely retained tertiary structure suggests that the intermediate represents a species in which a separate region of lower stability has been unfolded, rather than an intermediate of the 'molten globule' type. Such a structurally independent region is apparent in the three-dimensional structure of the inhibitor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544477     DOI: 10.1016/0014-5793(92)80102-m

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily.

Authors:  R A Staniforth; S Giannini; L D Higgins; M J Conroy; A M Hounslow; R Jerala; C J Craven; J P Waltho
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

2.  Thermal and guanidine hydrochloride-induced denaturation of human cystatin C.

Authors:  Elzbieta Jankowska; Wiesław Wiczk; Zbigniew Grzonka
Journal:  Eur Biophys J       Date:  2004-01-27       Impact factor: 1.733

3.  Differential scanning fluorimetric analysis of the amino-acid binding to taste receptor using a model receptor protein, the ligand-binding domain of fish T1r2a/T1r3.

Authors:  Takashi Yoshida; Norihisa Yasui; Yuko Kusakabe; Chiaki Ito; Miki Akamatsu; Atsuko Yamashita
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.